// STATE LEGISLATION TRACKER

Massachusetts HD 4096: An Act relative to animal telehealth

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: In committee

State: Massachusetts
Bill: HD 4096
Session: 194th
Filed: 2025-02-27
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

This bill is about veterinary telehealth for animal patients, not human medicine. Based on the title, subject, and available bill text, it does not appear to change access to compounded peptides, off-label prescribing, telehealth care for people, NP or naturopathic scope, or FDA 503A/503B compounding.

Key Points

No direct impact on human peptide users or clinicians
Applies to veterinary telehealth and animal patients
Does not appear to regulate compounded peptides
Does not change NP, naturopathic, or physician prescribing scope
Veterinary controlled-substance limits do not apply to human peptide care

What to Watch For

Note The bill is animal-health focused, so peptide patients should not treat it as a human telehealth bill.

Note Any drug-prescribing limits appear tied to veterinary care, not human off-label peptide prescribing.

Note No apparent change to 503A pharmacy or 503B outsourcing facility rules for human peptides.

Where the Bill Stands

The bill was referred to committee, with Senate concurrence on that referral rather than final passage.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws